LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Efficacy of convalescent plasma therapy for COVID-19: A systematic review and meta-analysis.

    Vegivinti, Charan T R / Pederson, John M / Saravu, Kavitha / Gupta, Nitin / Evanson, Kirk W / Kamrowski, Shelby / Schmidt, Megan / Barrett, Averi / Trent, Hannah / Dibas, Mahmoud / Reierson, Natalie L / Mikoff, Nick / Pisipati, Sailaja / Joseph, Betsy A / Selvan, Pragadeesh T / Dmytriw, Adam A / Pulakurthi, Yashwitha S / Keesari, Praneeth R / Sriram, Varsha /
    Chittajallu, Spandana / Brinjikji, Waleed / Katamreddy, Rewanth R / Chibbar, Richa / Davis, Amber R / Malpe, Manashree / Mishra, Hemant K / Kallmes, Kevin M / Hassan, Ameer E

    Journal of clinical apheresis

    2021  Volume 36, Issue 3, Page(s) 470–482

    Abstract: The purpose of this systematic review and meta-analysis was to examine clinical outcomes associated with convalescent plasma therapy in COVID-19 patients. We performed a literature search on PubMed, medRxiv, Web of Science, and Scopus to identify studies ...

    Abstract The purpose of this systematic review and meta-analysis was to examine clinical outcomes associated with convalescent plasma therapy in COVID-19 patients. We performed a literature search on PubMed, medRxiv, Web of Science, and Scopus to identify studies published up to December 10th, 2020 that examined the efficacy of convalescent plasma treatment for COVID-19. The primary endpoints were mortality, clinical improvement, and hospital length of stay. We screened 859 studies that met the search criteria, performed full-text reviews of 56 articles, and identified 15 articles that fulfilled inclusion criteria for meta-analysis. The odds of mortality were significantly lower in the convalescent plasma group compared to the control group (OR = 0.59 [95% CI = 0.44; 0.78], P < .001), although results from two key randomized controlled trials did not support the mortality benefit. The odds of clinical improvement were significantly higher in the convalescent plasma group compared to the control group (OR = 2.02 [95% CI = 1.54; 2.65], P < .001). There was no difference in hospital length of stay between the convalescent plasma group and the control group (MD = -0.49 days [95% CI = -3.11; 2.12], P = .713). In all, these data indicate that a mortality benefit with convalescent plasma is unclear, although there remain benefits with convalescent plasma therapy for COVID-19.
    MeSH term(s) COVID-19/mortality ; COVID-19/therapy ; Humans ; Immunization, Passive/methods ; Length of Stay ; Plasma ; Quality Assurance, Health Care ; Risk ; Treatment Outcome
    Language English
    Publishing date 2021-02-05
    Publishing country United States
    Document type Journal Article ; Meta-Analysis ; Systematic Review
    ZDB-ID 604912-6
    ISSN 1098-1101 ; 0733-2459
    ISSN (online) 1098-1101
    ISSN 0733-2459
    DOI 10.1002/jca.21881
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Primary central nervous system lymphoma: treatment access and outcomes in HIV positive patients in a minority rich cohort.

    Narvel, Hiba / Vegivinti, Charan / Vikash, Sindhu / Bazarbachi, Abdul Hamid / Pradhan, Kith / Wang, Shuai / Hammami, M Bakri / Narvel, Nida / Yakkali, Shreyas / Ansari, Shehbaz / Nabi, Adnan Gulam / Mohammed, Turab / Mantzaris, Ioannis / Konopleva, Marina / Goldfinger, Mendel / Gritsman, Kira / Cooper, Dennis / Shastri, Aditi / Shah, Nishi /
    Kornblum, Noah / Verma, Amit / Sica, R Alejandro

    Stem cell investigation

    2023  Volume 10, Page(s) 17

    Language English
    Publishing date 2023-08-24
    Publishing country China
    Document type Journal Article
    ZDB-ID 2884645-X
    ISSN 2313-0792 ; 2306-9759
    ISSN (online) 2313-0792
    ISSN 2306-9759
    DOI 10.21037/sci-2023-021
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top